| Values of mutations of K-ras oncogene at codon 12 in detection of pancreatic cancer: 15-year experience. | pancreatic, |
| Immunohistochemical analysis of the ras p21 oncoprotein in Hashimoto s thyroiditis. | thyroid, |
| Transcriptional basis of KRAS oncogene-mediated cellular transformation in ovarian epithelial cells. | ovarian, |
| GGT to GTT transversions in codon 12 of the K-ras oncogene in rat renal sarcomas induced with nickel subsulfide or nickel subsulfide/iron are consistent with oxidative damage to DNA. | sarcoma,kidney, |
| Effect of herbimycin A, an antagonist of tyrosine kinase, on bcr/abl oncoprotein-associated cell proliferations: abrogative effect on the transformation of murine hematopoietic cells by transfection of a retroviral vector expressing oncoprotein P210bcr/abl and preferential inhibition on Ph1-positive leukemia cell growth. | leukemia, |
| Successful growth and characterization of mouse pancreatic ductal cells: functional properties of the Ki-RAS(G12V) oncogene. | pancreatic, |
| Mutational spectrum of K-ras oncogene among Indian patients with gallbladder cancer. | bladder, |
| Inducible activation of oncogenic K-ras results in tumor formation in the oral cavity. | oral |
| An anti-K-ras ribozyme suppresses oncogene expression and cell growth of human pancreatic cancer. | pancreatic, |
| Mutations of BRAF or KRAS oncogenes are early events in the serrated polyp neoplasia pathway. CpG island methylation plays a role in serrated polyp progression to colorectal carcinoma. | colorectal, |
| A novel high-specificity approach for colorectal neoplasia: Detection of K-ras2 oncogene mutation in normal mucosa. | colorectal, |
| Flow cytometric analysis of DNA content and RAS P21 oncoprotein expression in ovarian neoplasms. | neoplasm,ovarian, |
| Cyclooxygenase-2 is a target of KRASD12, which facilitates the outgrowth of murine C26 colorectal liver metastases. | colorectal,liver, |
| Mice carrying mutant p53 transgene are more sensitive to environmental cigarette smoke(ECS)-induced lung tumors. K-ras mutations are independent of p53 status, but early overexpression of oncogene is related to p53 status in ECS-exposed mice. | lung, |
| Low levels of ras p21 oncogene expression correlates with clinical outcome in head and neck squamous cell carcinoma. | HNSC, |
| Transcriptional targets of hepatocyte growth factor signaling and Ki-ras oncogene activation in colorectal cancer. | colorectal, |
| hepatocyte growth factor signaling and Ki-ras oncogene activation have roles in colorectal cancer | colorectal, |
| Immunohistochemical analysis of ras oncogene p21 product in human gastric carcinomas and their adjacent mucosas. | gastric, |
| p53-Independent negative regulation of p21/cyclin-dependent kinase-interacting protein 1 by the sonic hedgehog-glioma-associated oncogene 1 pathway in gastric carcinoma cells. | gastric,glioma, |
| Crude isolation of DNA from unselected human pancreatic tissue and amplification by the polymerase chain reaction of Ki-ras oncogene to detect point mutations in pancreatic cancer. | pancreatic, |